Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Recs

0
Player Avatar fundamentalsrock (33.51) Submitted: 2/2/2011 4:19:38 PM : Outperform Start Price: $71.46 ILMN Score: -40.06

DNA sequencing is moving into mainstream pharma, and Illumina has the market share and technology. They will dominate for the foreseeable future a fast, fast growing market. The Intel of biotech.

Featured Broker Partners


Advertisement